Fractional Flow Reserve Evaluation and Chronic Kidney Disease: Analysis From a Multicenter Italian Registry (the

Matteo Tebaldi1, Simone Biscaglia2, Massimo Fineschi3

  • 1Cardiovascular Institute, Azienda Ospedaliero-Universitaria Di Ferrara, Cona, Ferrara, Italy. tblmtt@unife.it.

Insights

Chronic kidney disease (CKD) may affect fractional flow reserve (FFR) measurements in patients with coronary stenosis. Flow-limiting FFR was less frequent in CKD patients, suggesting potential differences in microcirculation assessment.

Area of Science:

  • Cardiology
  • Nephrology
  • Medical Diagnostics

Background:

  • Fractional flow reserve (FFR)-guided revascularization improves outcomes in coronary artery disease.
  • Chronic kidney disease (CKD) is linked to impaired microcirculation and increased cardiovascular risk.
  • The impact of CKD on FFR accuracy remains unclear.

Purpose of the Study:

  • To determine if CKD influences FFR values in patients with intermediate coronary stenosis.
  • To investigate the relationship between CKD and FFR measurements.
  • To assess microcirculatory resistance (IMR) in relation to CKD.

Main Methods:

  • A multicenter prospective registry of 1,004 patients undergoing FFR evaluation.
  • CKD defined as creatinine clearance (CrCl) ≤45 ml/min.
  • IMR calculated in a substudy of 20 patients stratified by CrCl.

Main Results:

  • Patients with CKD (CrCl ≤45 ml/min) had significantly higher FFR values (0.84±0.07 vs. 0.81±0.08, p<0.001).
  • Positive FFR was less common in CKD patients (27% vs. 41%, p<0.01).
  • CKD (CrCl ≤45 ml/min) was an independent predictor of FFR measurement (HR 0.92, p=0.005), and IMR was higher in CKD patients (32 U vs. 16 U, p<0.01).

Conclusions:

  • FFR and IMR measurements differ between CKD patients and those with normal renal function.
  • Flow-limiting FFR is less frequent in patients with CrCl ≤45 ml/min.
  • CKD status should be considered when interpreting FFR and IMR in intermediate coronary stenosis.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
307
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
102
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
609
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
304
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
549
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
574